Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash Flows from Operating Activities:
Net Loss	$ (1,687,501)	$ (30,549,183)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:
Stock for services and compensation	483,450	26,861,097
Loss on settlement of debt	209,598	434,570
Write-off of inventory	0	69,649
Write-off of property and equipment	0	101,350
Stock issued for litigation settlement	0	312,000
Amortization of debt discount	16,533	608,710
Amortization expense	4,050	0
Stock received as other income	(808,781)
Changes in assets and liabilities:
Inventory	(34,730)	25
Prepaid and other current assets	(17,932)	(5,000)
Accounts payable and accrued expenses	638,721	693,692
Accrued litigation settlement	280,000	120,000
Accrued liabilities - related party	296,872	525,011
Net Cash Used In Operating Activities	(619,720)	(828,079)
Cash Flows from Investing Activities:
Purchase of patents	(40,500)
Net Cash Used In Investing Activities	(40,500)	0
Cash Flows from Financing Activities:
Repayment to on loan payable - related parties	(226,275)	(36,500)
Proceeds from loan payable - related parties	383,275	245,500
Repayments on promissory note payable	(90,864)	0
Repurchase of common stock	(50,000)
Proceeds from convertible notes payable - related party	93,000	0
Proceeds from convertible notes payable	392,975	115,000
Payment of offering costs	(26,200)
Proceeds from issuance of common stock	175,887	479,802
Net Cash Provided By Financing Activities	651,798	803,802
Increase (decrease) in Cash and Cash Equivalents	(8,422)	(24,277)
Cash and Cash Equivalents - Beginning of period	21,799	46,076
CASH AND CASH EQUIVALENTS - END OF PERIOD	13,377	21,799
Supplemental cash flow information:
Cash paid for interest	12,871	0
Cash paid for income taxes	0	0
Schedule of Non-Cash Financing Activities:
Cancellation of common stock	250	117
Common stock issued for commitment fee	250,000	0
Common stock issued to settle accrued liabilities - related party	127,500	561,148
Common stock issued to settle accounts payable and accrued liabilities	203,126	190,000
Accrued litigation settlement paid with loan payable	100,000	0
Debt discount related to beneficial conversion feature	0	234,912
Conversion of accounts payable and accrued liabilities to convertible notes payable	0	90,000
Accrued liabilities - related party converted to convertible notes payable - related party	0	112,500
Loans payable - related party converted to convertible notes payable - related party	372,000	0
Conversion of accrued liabilities - related party to loans payable - related parties	0	30,000
Common stock issued to settle related party advances	0	20,000
Common stock issued for conversion of convertible notes payable and accrued interest	206,849	590,467
Common stock issued for conversion of convertible notes payable and accrued interest - related party	0	676,555
Convertible notes payable and accrued interest- related party converted to convertible notes payable and accrued interest	$ 0	176,502
Common stock issued for subscription receivable	50,550
Debt discount related to original issue discount	$ 49,525	0
Amortization of deferred offering costs	$ 6,961	$ 0